Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate Cancer

Number of Prescription Medications and Overall Survival in Metastatic Castrate-Resistant Prostate Cancer

Conclusions: The number and type of medications were independently associated with survival in patients undergoing treatment for mCRPC. With new therapies for treatment of advanced prostate cancer, patients are living longer, which increases the need for better understanding of the impact of comorbi...

Full description

Saved in:
Bibliographic Details
Main Authors: Carley R. Pickett, Daniel B. Eaton, Krishny Karunanandaa, Emily Cybulla, Brendan T. Heiden, Su-Hsin Chang, Yan Yan, Melanie P. Subramanian, Varun Puri, Martin W. Schoen
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/proc/6863066
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items